Wednesday, June 06, 2007

Genentech's Inclusive Project Planning and Execution Approach ...
Pharmaceutical Processing - Rockaway,NJ,USA
This led to a decision to produce the potentially blockbuster Tysabri (natalizumab), a monoclonal antibody for the management of multiple sclerosis at the ...
See all stories on this topic

Nova Chemicals Reveals New Appointments For Proposed Expanded ...
RTT News - Williamsville,NY,USA
According to the National Multiple Sclerosis Society,"NMSS", the direct costs of medical care for MS patients in the United States exceed $6 billion ...
See all stories on this topic

0 Comments:

Post a Comment

<< Home